Mandate

Vinge advises EQT Infrastructure and Meine Radiologie / Blikk in connection with the acquisition of Aleris’ radiology business

Vinge advises EQT Infrastructure and its portfolio companies Meine Radiologie Holding GmbH and Blikk Holding GmbH in connection with the acquisition of Aleris’ radiology business.

The acquisition includes the full operation of the business area radiology, with 22 units in Sweden and 14 in Norway as well as teleradiology operations in the Baltics, which together carry out more than 1 million radiology exams annually across a broad range of diagnostic imaging modalities.

The acquisition is subject to approval from applicable competition authorities.

Vinge’s team consisted of partner Daniel Rosvall together with Carl Sander, Elsie Nassar, Clara Sohlberg and Ebba Nyberg (M&A), Sam Fakhraie Ardekani (Commercial Agreements), Benjamin Vafaeian (Banking and Financing), Christoffer Nordin (Regulatory and permits), Ulf Pyk (Real Estate), Tove Lövgren Frisk (Compliance), Gustav Lindgren (Employment), Lisa Hörnqvist and Karolina Fuhrman (IT and GDPR), Jolene Reimerson (Separation), Emma Gustavsson (IPR) and Ellinor Gyllenhammar (Project and VDR Assistant).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026